Descriptive View on Candida Auris Occurrence in a Tertiary Health Institution in Riyadh, Saudi Arabia

Alshahrani, Fatimah S.; Elgujja, Abba Amsami; Alsubaie, Sara; Ezreqat, Salah Ahmed; Albarrag, Ahmed M.; Barry, Mazin; Khamis, Khalifa Bin; Alabdan, Lulwa

doi:10.20944/preprints202310.0546.v1

Cited by 1 publication

(1 citation statement)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the uniform score may not fully capture the nuanced differences in risk associated with distinct comorbidities or varying degrees of MDRO exposure. [21] Considering international exposure, with a score of 1 assigned to patients with a "history of admission to hospital outside the KSA (within the past 12 months)", acknowledges the potential risk associated with recent foreign hospitalization. Likewise, a score of 1 for the "presence of wounds or indwelling devices" emphasizes the signi cance of these devices as potential entry points for infections.…”

Section: Discussionmentioning

confidence: 99%

Adoption and Use of a Risk Assessment Tool for Identifying and Controlling the Spread of Candida Auris among Admitted Patients at a Saudi Arabian Hospital

Alshahrani,

Elgujja,

Alsubaie

et al. 2024

Preprint

Self Cite

View full text Add to dashboard Cite

Background The emergence of Candida auris (C. auris), a multidrug-resistant fungal pathogen, poses a significant healthcare challenge, necessitating robust risk assessment strategies for effective infection control in hospital settings. Objective This study aimed to assess and quantify the risk of C. auris infection in a tertiary hospital using an adapted risk assessment tool considering diverse patient factors and hospital dynamics. Method The study employed the 'adaptation method,' amalgamating literature review and analysis of individual patient data (IPD) to identify and quantify C. auris infection risk. Utilizing the MRSA risk assessment tool, risk factor information was derived from the literature and adapted based on IPD, ensuring context-specific relevance. The study was conducted in a 1000-bed tertiary university teaching hospital in Riyadh, triggered by the first C. auris case in 2019, covering the period from January 2020 to December 2022. The variables included admission history, comorbidities, multidrug resistant organism (MDRO) history, wounds/devices, surgeries, and antimicrobial use. The inclusion criteria targeted high-risk individuals, and the exclusion criteria focused on inpatients. The screening tool was deployed through a PowerForm in selected nursing units, with rigorous training for nurses and comprehensive data collection, monitoring, and outcome analysis. Robust statistical methods, including multivariable logistic regression and subgroup analyses, were employed to address potential biases and ensure the study's internal validity. Results Graphic and clinical findings were analyzed in a cohort of 68,031 patients. Notably, 9% of the patients had identified risk factors, such as septicemia, CKD, DM, or chronic lung disease. Additionally, 7% reported a history of admission to non-KSA hospitals, and 14% had contact with MDROs or ASCs. The overall prevalence of positive responses across the assessed risk factors was 6%, underscoring the relevance of these factors in the context of Candida auris infection. Conclusion The overall prevalence of positive responses across the assessed risk factors was 6%, emphasizing the relevance of these factors in the context of Candida auris infection. These findings contribute valuable insights for developing targeted surveillance and preventive measures in the healthcare setting.

show abstract

Section: Discussionmentioning

confidence: 99%